Clarametyx Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $33M

  • Investors
  • 9

Clarametyx Biosciences General Information

Description

Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. The company's novel technology platform targets the protective barrier around bacteria through biological therapies, enabling healthcare professionals to target the challenging infections fueled by biofilms and reduce antibiotic resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Energy Advancement & Innovation Center
  • 2281 Kenny Road, Suite 410
  • Columbus, OH 43210
  • United States
+1 (614)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Energy Advancement & Innovation Center
  • 2281 Kenny Road, Suite 410
  • Columbus, OH 43210
  • United States
+1 (614)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clarametyx Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A1) 17-Jul-2025 $33M Completed Clinical Trials - Phase 2
4. Grant 01-Jan-2021 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 25-Jan-2021 Completed Pre-Clinical Trials
2. Grant 18-Nov-2020 $14.3M $3M Completed Pre-Clinical Trials
1. Seed Round 01-May-2020 $3M $3M Completed Startup
To view Clarametyx Biosciences’s complete valuation and funding history, request access »

Clarametyx Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Clarametyx Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Clarametyx Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. The company's novel te
Drug Discovery
Columbus, OH
14 As of 2022

South San Francisco, CA
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Clarametyx Biosciences Competitors (97)

One of Clarametyx Biosciences’s 97 competitors is Shinobi Therapeutics, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Shinobi Therapeutics Venture Capital-Backed South San Francisco, CA
Trellis Bioscience Venture Capital-Backed Redwood City, CA
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Enterprise Therapeutics Venture Capital-Backed Brighton, United Kingdom
You’re viewing 5 of 97 competitors. Get the full list »

Clarametyx Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clarametyx Biosciences Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Candice Venture Fund Venture Capital Minority
CincyTech Venture Capital Minority
Kineticos Life Sciences Management Venture Capital Minority
JobsOhio Ventures Venture Capital Minority
Nationwide Children's Hospital VC-Backed Company Minority
You’re viewing 5 of 9 investors. Get the full list »

Clarametyx Biosciences FAQs

  • When was Clarametyx Biosciences founded?

    Clarametyx Biosciences was founded in 2019.

  • Where is Clarametyx Biosciences headquartered?

    Clarametyx Biosciences is headquartered in Columbus, OH.

  • What is the size of Clarametyx Biosciences?

    Clarametyx Biosciences has 14 total employees.

  • What industry is Clarametyx Biosciences in?

    Clarametyx Biosciences’s primary industry is Drug Discovery.

  • Is Clarametyx Biosciences a private or public company?

    Clarametyx Biosciences is a Private company.

  • What is the current valuation of Clarametyx Biosciences?

    The current valuation of Clarametyx Biosciences is .

  • What is Clarametyx Biosciences’s current revenue?

    The current revenue for Clarametyx Biosciences is .

  • How much funding has Clarametyx Biosciences raised over time?

    Clarametyx Biosciences has raised $44M.

  • Who are Clarametyx Biosciences’s investors?

    Candice Venture Fund, CincyTech, Kineticos Life Sciences Management, JobsOhio Ventures, and Nationwide Children's Hospital are 5 of 9 investors who have invested in Clarametyx Biosciences.

  • Who are Clarametyx Biosciences’s competitors?

    Shinobi Therapeutics, Trellis Bioscience, Aro Biotherapeutics, Cristal Therapeutics, and Enterprise Therapeutics are some of the 97 competitors of Clarametyx Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process